Hikma Pharmaceutical reported 5.66B in Market Capitalization for its first fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Almirall ALM:SM 2.64B 341.48M
Argen X Bv ARGX:BB 12.99B 1.05B
AstraZeneca AZN:LN 113.99B 18.86B
Bayer BAYN:GR 50.48B 2.53B
Fresenius FRE:GR 24.63B 3.46B
Fresenius Medical Care FMS:US 24.33B 2.78B
Galapagos GLPG:NA 3.83B 499.87M
Genmab GEN:DC 168.38B 31.59B
GlaxoSmithKline GSK:LN 70.63B 794.04M
GRIFOLS GRF:SM 13.6B 337.76M
H. Lundbeck A/S LUN:DC 39.73B 3.43B
Hikma Pharmaceutical HIK:LN 5.66B 142.14M
Lonza Group LONN:SW 48.84B 6.48B
Merck MRK:GR 20.9B 2.08B
Orion ORNBV:FH 4.84B 278.77M
Recordati REC:IM 10.08B 487.26M
Sanofi SAN:FP 111.4B 5.33B
UCB UCB:BB 17.15B 715.78M